Table 1 (abstract P128). Differences of IMT values according to ENA profile or treatment
From: Proceedings of the 25th European Paediatric Rheumatology Congress (PReS 2018)
| Â | negative/untreated | positive/treated | p-value | ||
|---|---|---|---|---|---|
median (μ) | IQR | median (μ) | IQR | ||
Anti-SM | 398 | 18 | 359 | 17 | 0,97 |
Anti-SSA/Ro | 359 | 57 | 389 | 44 | 0,73 |
Anti-SSB/La | 396 | 63 | 359 | 45,5 | 0,12 |
U1-RNP | 398 | 18 | 342 | 20 | 0,0232 |
azathioprine | 392,5 | 70,5 | 366 | 59 | 0,9 |
ciclophospamide | 392,5 | 49,25 | 359 | 88,5 | ns |
idroxicloroquine | 359 | 65 | 400,5 | 56,25 | 0,13 |